Decoding Quality Terminology

By Jennifer Dawson, MHA, LSSBB, DLM(ASCP)  bio Editor's Note: G2 Compliance is pleased to announce our upcoming webinar, The Cost of Poor Quality, with Jennifer Dawson. Registration details … [Read more...]


By the Numbers: Lab Injury and Exposure Data

By Dan Scungio, MT (ASCP), SLS, CQA (ASQ)  bio Finding information about the number of Laboratory Acquired Infections (LAIs) and other laboratory injuries in the United States is difficult. … [Read more...]


Do No Harm: Diagnostic Errors and the Lab

By Jennifer (McMahon) Dawson, MHA, DLM (ASCP)  bio "Do no harm" is the mantra that health care providers live by. Doctors, nurses and laboratory professionals alike enter into the business … [Read more...]


2016 Year End Brought Closure to Many Diagnostic Deals

As 2016 came to a close, so too did a significant number of business deals involving diagnostic companies, tests and testing systems. Here's a summary of some of the recent transactions affecting … [Read more...]


Theranos Shifts Focus from Labs to Technology

Theranos announced that it will shut down its laboratory operations in wake of the Centers for Medicare and Medicaid's Services (CMS) sanctions resulting from the 2015 inspection of its Newark, … [Read more...]


Labs Must Rapidly Implement Zika Blood Supply Testing

The U.S. Food and Drug Administration (FDA) recently classified the Zika virus as a transfusion-transmitted infection and called on all U.S. blood centers to start universal screening of donated whole … [Read more...]


Diabetes Screening in ER Improves Detection in High Prevalence Areas

Routine glycated hemoglobin (HbA1c) testing in urban emergency departments identifies a large number of people with undiagnosed diabetes and prediabetes, according to a study published June 3 in BMJ … [Read more...]


Reference Pricing Cuts Prices for Lab Tests by One-Third

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Reference pricing is associated with nearly a one-third reduction in the average price paid for 285 different types of tests, … [Read more...]


Corporate Venture Capital Ups Investments in Health Deals

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Health care corporate venture capital (CVC) is increasing across all sectors of the industry in terms of number of deals, dollars … [Read more...]


U.S. Colorectal Cancer Screening Capacity Exists, Although Actual Rates Remain Low

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies The United States has the screening capacity to meet colorectal screening goals, but this capacity has so far not translated into … [Read more...]